Tempus AI, Predicta Expand Genomics Test for Blood Cancer
Chicago, Illinois, U.S. | April 15, 2026 Tempus AI, Inc., in collaboration with Predicta Biosciences, has announced the expansion...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Chicago, Illinois, U.S. | April 15, 2026 Tempus AI, Inc., in collaboration with Predicta Biosciences, has announced the expansion...
BALTIMORE, MARYLAND, USA, April 13, 2026 Protaryx Medical has received U.S. FDA 510(k) clearance for its Transseptal Puncture Device,...
SYDNEY, Australia & NEW YORK, United States, April 8, 2026 Lumonus, a healthcare technology company specializing in AI-driven radiation...
NEW YORK & CAMBRIDGE, Mass., USA, March 30, 2026 Blackstone has announced the final close of Blackstone Life Sciences...
BESANÇON, France, March 24, 2026 Pixee Medical has announced the U.S. launch of its Knee+ NexSight augmented reality (AR)...
CHICAGO, Dec. 29, 2025 — GE HealthCare announced that its senior management team will present at an upcoming January...
WARSAW, Ind., December 16, 2025 — Zimmer Biomet Holdings, Inc., a global leader in medical technology, has entered into...
WHITE BEAR LAKE, Minn., Dec. 10, 2025 — Envoy Medical announced the successful first set of activations in the...
STAMFORD, CT, September 25, 2025 — Apiject Systems, Corp., a leading medical technology innovator, submitted its New Drug Application...
